A new colorimetric assay for studying and rapid screening of membrane penetration enhancers

被引:37
作者
Evrard, D
Touitou, E
Kolusheva, S
Fishov, Y
Jelinek, R [1 ]
机构
[1] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Stadler Minerva Ctr Mesoscale Macromol Engn, IL-84105 Beer Sheva, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Dept Pharmaceut, IL-91120 Jerusalem, Israel
[4] Ben Gurion Univ Negev, Dept Life Sci, Beersheva, Israel
关键词
penetration enhancers; membrane permeation; biosensors; polydiacetylene;
D O I
10.1023/A:1010980009823
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. This work aims to demonstrate a novel chemical assay for rapid screening and analysis of the mode of action of membrane interaction by penetration enhancers. Methods. The new bio-mimetic membrane assembly, consisting of supramolecular aggregates of lipids and conjugated polydiacetylene, undergoes visible and quantifiable blue-red color transitions upon interaction with penetration enhancers. Results. The new colorimetric model has been employed to examine various classes of penetration enhancers, including 1-dodecylhexahydro-2H-azepin-2-one (Azone). oleic acid, propylene-glycol, menthol, ethoxyglycol-diethyleneglycol-monoethyl-ether (Transcutol), polysorbate-polyethylenesorbitan-monolaurate (Tween-20), and the drug 7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one (Diazepam). The assay enables to evaluate the validity of various observations and hypotheses proposed in previous studies regarding permeation enhancement activities. Our results suggest, for example, that propylene glycol (PG) by itself does not interfere with membranes, but rather exhibits synergistic effect in combination with other penetration enhancers. Similarly, our data demonstrate that Transcutol does not independently interact with membranes. The colorimetric system also indicates that interaction of penetration enhancers with membranes depend upon the lipid phase, as well as the self-assembly properties of the enhancer molecules. Conclusions. The new biomimetic model membrane system can be applied for rapid screening of the activities of penetration enhancers, and provides insight into the mechanisms of permeability of membrane-active compounds.
引用
收藏
页码:943 / 949
页数:7
相关论文
共 34 条
[1]   LIPID-PROTEIN-PARTITIONING THEORY OF SKIN PENETRATION ENHANCEMENT [J].
BARRY, BW .
JOURNAL OF CONTROLLED RELEASE, 1991, 15 (03) :237-248
[2]   THERMODYNAMIC AND STRUCTURAL ASPECTS OF THE SKIN BARRIER [J].
BOUWSTRA, JA ;
DEVRIES, MA ;
GOORIS, GS ;
BRAS, W ;
BRUSSEE, J ;
PONEC, M .
JOURNAL OF CONTROLLED RELEASE, 1991, 15 (03) :209-220
[3]  
CHANCE RR, 1980, MACROMOLECULES, V13, P386
[4]   DIRECT COLORIMETRIC DETECTION OF A RECEPTOR-LIGAND INTERACTION BY A POLYMERIZED BILAYER ASSEMBLY [J].
CHARYCH, DH ;
NAGY, JO ;
SPEVAK, W ;
BEDNARSKI, MD .
SCIENCE, 1993, 261 (5121) :585-588
[5]   Amino acid terminated polydiacetylene lipid microstructures: Morphology and chromatic transition [J].
Cheng, Q ;
Yamamoto, M ;
Stevens, RC .
LANGMUIR, 2000, 16 (12) :5333-5342
[6]   The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems [J].
El-Kattan, AF ;
Asbill, CS ;
Michniak, BB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 198 (02) :179-189
[7]   AN ELECTRON-SPIN RESONANCE STUDY OF SKIN PENETRATION ENHANCERS [J].
GAY, CL ;
MURPHY, TM ;
HADGRAFT, J ;
KELLAWAY, IW ;
EVANS, JC ;
ROWLANDS, CC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 49 (01) :39-45
[8]   ROLE OF STRATUM-CORNEUM LIPID FLUIDITY IN TRANSDERMAL DRUG FLUX [J].
GOLDEN, GM ;
MCKIE, JE ;
POTTS, RO .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (01) :25-28
[9]   Permeability of chemical delivery systems across rabbit corneal (SIRC) cell line and isolated corneas: A comparative study [J].
Goskonda, VR ;
Hill, RA ;
Khan, MA ;
Reddy, IK .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2000, 5 (03) :409-416
[10]   The relative effect of Azone(R) and Transcutol(R) on permeant diffusivity and solubility in human stratum corneum [J].
Harrison, JE ;
Watkinson, AC ;
Green, DM ;
Hadgraft, J ;
Brain, K .
PHARMACEUTICAL RESEARCH, 1996, 13 (04) :542-546